Leading the Way in Life Science Technologies

GEN Exclusives

More »

January 15, Vol. 30, No. 2

  • Feature Articles

    • Cancer Biomarker Chase Accelerates
    • James Netterwald, Ph.D.
    • Expanding faster than the largest supernova, cancer biomarker development has become the priority of every single public and private entity performing cancer research nowadays Evidence of this expansion comes in the form of multiple scientific conferences covering the topic One ... more »
    • OEMs Redefine Role in Biotech Sector
    • Gail Dutton
    • OEMs—original equipment manufacturers—have existed in the life sciences for decades but are becoming increasingly popular with providers of microfluidics, liquid-handling, and assay systems and components that are used for drug development, as well as other biotech applications... more »
    • RNAi Moves One Step Closer to Clinic
    • Elizabeth Lipp
    • As more of the human genome is identified and characterized, new frontiers open for therapeutics “The RNA interference (RNAi) research space continues to explode,” explains Susan Magdaleno, PhD, senior manager of scientists, RNAi technologies R&D, Life Technologies “We are actually ... more »
    • GEN's ELISA REDUX Cryptogram Solved
    • An astronomer and a neuroscientist have solved GEN’s Cryptogram Challenge: ELISA REDUX The two grad students, Charles Steinhardt, from the department of astronomy at Harvard University, and Forrest Collman, from the Tank Lab in the Lewis-Sigler Institute for Integrative Genomics ... more »